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Abstract
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Stimulation of the posterior hypothalamic area (PH) produces antinociception in rats and humans,
but the precise mechanisms are unknown. The PH forms anatomical connections with the
parabrachial area, which contains the pontine A7 catecholamine cell group, a group of spinally
projecting noradrenergic neurons known to produce antinociception in the dorsal horn. The aim of
the present study was to determine whether PH-induced antinociception is mediated in part
through connections with the A7 cell group in female Sprague-Dawley rats, as measured by the
tail flick and foot withdrawal latency. Stimulation of the PH with the cholinergic agonist carbachol
(125 nmol) produced antinociception that was blocked by pretreatment with atropine sulfate.
Intrathecal injection of the α2-adrenoceptor antagonist yohimbine reversed PH-induced
antinociception, but the α1-adrenoceptor antagonist WB4101 facilitated antinociception.
Intrathecal injection of normal saline had no effect. In a separate experiment, cobalt chloride,
which reversibly arrests synaptic activity, was microinjected into the A7 cell group and blocked
PH-induced antinociception. These findings provide evidence that the PH modulates nociception
in part through connections with the A7 catecholamine cell group through opposing effects.
Antinociception occurs from actions at α2-adrenoceptors in the dorsal horn, while concurrent
hyperalgesia occurs from actions of norepinephrine at α1-adrenoceptors. This hyperalgesic
response likely attenuates antinociception from PH stimulation.

1. Introduction
NIH-PA Author Manuscript

The posterior hypothalamic area (PH) has been shown to modulate nociception in both
animal and clinical studies. In rat, electrical stimulation of the PH produces potent
antinociception (Rhodes and Liebeskind, 1978) and chemical stimulation reduces facial pain
in rats (Bartsch et al. 2004). Increases in c-fos positive (activated) cells in the PH are seen
after administration of an electrical pain stimulus (Gavrilov et al., 2008) and destruction or
deactivation of the PH increases pain responses (Millan et al., 1983; Manning and Franklin,
1998). MicroPET studies show PH activation and neuroplastic changes involving latent pain
sensitization following surgery (Romero et al., 2011) and after application of a heat stimulus
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to an inflamed paw (Hess et al., 2007). Clinical stimulation of the PH has been done
effectively for debilitating neurovascular cluster headaches, (Goadsby, 2007; Bartsch et al,
2008; May, 2008; Brittain et al., 2009; Jurgens et al., 2009; Leone and Bussone, 2009;
Leone et al., 2010), intractable short lasting unilateral neuralgiform headache with
conjunctival tearing,(Bartsch et al., 2011; Leone et al., 2005), chronic paroxysmal
hemicranias (Walcott et al., 2009), and refractory paroxysmal pain for trigeminal neuralgia
(Cordella et al., 2009). While these studies support the notion that the PH is involved in the
descending modulation of nociception, they do not indicate the mechanisms of this
involvement.
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Recently, we reported that stimulating the PH with the cholinergic agonist carbamylcholine
chloride (carbachol) significantly decreases neuropathic pain from constriction of the sciatic
nerve, in part through mediation by orexin receptors in the spinal cord dorsal horn (Jeong
and Holden, 2009). In other studies, we reported that stimulating the lateral hypothalamus
with carbachol produces antinociception mediated in part by α2-adrenoceptors and
facilitated by α1 adrenoceptors in a rat model of acute nociception (Holden and Naleway,
2001), via connections with the spinally-projecting A7 catecholamine cell group in the pons
(Holden et al., 2002). During these experiments we observed that inadvertent placement of
the microinjector in the PH also produced antinociception and that alpha-adrenoceptors in
the dorsal horn may have been involved. This observation coupled with the observations of
our orexin study led us to further investigate the mechanisms of PH-induced nociceptive
modulation.
The involvement of the A7 catecholamine cell group in descending nociceptive modulation
has been well documented over several decades. In Sprague-Dawley derived rats from Sasco
(West et al., 1993), the A7 cell group is the major source of noradrenergic innervation to
laminae I-IV in the dorsal horn (Clark and Proudfit, 1991; Proudfit, 1992). Laminae I-IV are
the terminal field of primary afferent nociceptors and contain second order spinothalamic
tract neurons (Light, 1992). Synaptic terminals that contain dopamine-β-hydroxylase appear
to form synapses both with identified spinothalamic tract neurons (Westlund et al., 1990),
and with unidentified dorsal horn neurons (Hagihira et al., 1990; Doyle and Maxwell,
1991a; Doyle and Maxwell, 1991b). Behavioral studies have shown that stimulating the A7
area using electrical or chemical applications produces nociceptive modulation (Yeomans et
al., 1992; Yeomans, 1992; Holden et al., 1999; Nuseir et al., 1999; Nuseir and Proudfit,
2000; Holden and Naleway, 2001; Min et al., 2008; Bajic and Commons, 2010; Min et al.,
2010).
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While tyrosine hydroxylase immunoreactive neurons have been labeled in the PH, there is
no evidence that these neurons are spinally-projecting noradrenergic neurons (Abrahamson
and Moore, 2001), and it has been documented that the A5, A6 and A7 areas provide the
only source of noradrenergic innervation to the spinal cord (Westlund et al., 1981; Westlund
et al., 1983; Bruinstroop et al., 2011). However, the PH does send axonal projections to the
parabrachial area, including the A7 area, in monkey (Veazey et al., 1982) and in rat (Vertes
and Crane, 1996). In rat, the connection appears to be reciprocal (Cavdar et al., 2001). These
findings support the hypothesis that stimulating the PH produces antinociception in part by
recruiting the A7 cell group.
To test this hypothesis, three experiments were conducted. In the first experiment, either
carbachol or normal saline was microinjected into the PH of rats and nociceptive testing was
done using the tail flick and foot withdrawal latency tests. To determine whether PHinduced antinociception is mediated by α-adrenoceptors in the spinal cord dorsal horn, in the
second experiment the PH was stimulated to obtain antinociception and then intrathecal (IT)
injection of α-adrenoceptor antagonists were given. In the final experiment, the PH was
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stimulated and then cobalt chloride was microinjected into the A7 area to block synaptic
activity. Taken together, these experiments provide behavioral evidence that PH-induced
antinociception is mediated in part by the A7 cell group noradrenergic input to the spinal
cord dorsal horn. A preliminary account of these results has been published as an abstract
(Jeong and Holden, 2005).

2. Experimental Procedures
The Institutional Animal Care Committees at the University of Illinois at Chicago and the
University of Michigan approved the experimental protocols used in this study. The
experiments were conducted in accordance with the National Institutes of Health Guide for
the Care and Use of Laboratory Animals (NIH Publications No. 80–23, revised 1996). All
efforts were made to minimize animal suffering, reduce the numbers of animals used, and
use alternatives to in vivo experiments.
Animals
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Female Sprague-Dawley rats (250–350 g; Charles River, Portage, MI) were used in this
study because our previous work was done in females. All rats were maintained on a 12hour day/night schedule with free access to food and water. To reduce the possibility of
estrous cycle influence, rats were randomly assigned to either experimental or control
groups and no two rats were taken from the same cage on the same day. Seventy one rats
were used for the study as reported, and each rat was used only once.
Analgesiometric testing procedures
To determine the effect of PH stimulation on thermal nociception, the tail flick and foot
withdrawal tests were used. In these procedures, a focused beam of high intensity light from
a suspended 250-W projection bulb was directed at the dorsal surface of the tail and the
hairy surface of the hind feet. The distance from the light to the platform the rats lay on was
maintained at 5 cm for all experiments. The tail and paws were blackened with India ink to
facilitate even heating of the skin surface. The time interval between the onset of skin
heating and the withdrawal response was measured electronically. In the absence of a
response, skin heating was terminated after 8 sec to prevent burning. Three response
latencies were measured in succession at three places on the tail. The average of the three
tail latency values was defined as the nociceptive response latency. For the foot withdrawal,
response latencies were measured at one place on the hairy surface of each hind foot.
Baseline response latencies of the paws and tail were approximately 2–3 s, as used in
previous studies.
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Experiment 1: Carbachol or saline microinjection in the PH—Each rat was lightly
anesthetized with sodium pentobarbital 35 mg/kg, IP, and the scalp was infused with the
local anesthetic bupivacaine (0.25%; 0.10 ml). Supplemental doses of pentobarbital were
given during the procedure if the rats vocalized or moved without stimulation, but were
rarely required. Immediately after anesthesia, the midline scalp was shaved and the rats were
immobilized in a stereotactic apparatus. Using aseptic technique, a 2-cm incision was made,
and the muscle and fascia retracted. A 23-gauge stainless steel guide cannula was lowered
through a burr hole into the region of the left PH defined by the following stereotactic
coordinates: AP −3.1 mm from bregma, lateral −0.5 mm, vertical +2.1 mm, incisor bar set at
−2.5 mm. A 30-gauge stainless steel injection cannula was connected to a 10 μl syringe by a
length of PE-10 polyethylene tubing filled with either saline or a solution of carbachol 125
nmol in normal saline injected in a volume of 0.5 μl (Sigma Chemical Co., St. Louis, MO;
All solutions were made fresh daily and filtered through a 0.2 μm syringe prior to use.). The
injection cannula was then inserted and extended approximately 3 mm beyond the end of the
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guide cannula. After a baseline response latency measurement was taken and recorded,
either saline or carbachol was injected into the PH over a 1-min period using an electronic
syringe pump. The injection cannula was left in place for an additional 60 s following
completion of the microinjection to reduce flow of drug up the guide cannula. Response
latencies were then measured at 5 min intervals until a return to baseline or for 45 min. A
separate group of rats was prepared as above, but the PH was pretreated with the cholinergic
antagonist atropine sulfate (5 μg/0.5 μl NS) microinjected over 1 min. Carbachol (125 nmol)
was then injected and tail flick and foot withdrawal latencies were measured.

NIH-PA Author Manuscript

Experiment 2: Carbachol microinjection in the PH followed by microinjection
of IT α-adrenergic antagonists—Female Sprague-Dawley rats (Charles River; 250–350
g) were randomly assigned to groups and prepared for microinjection in the PH as
previously described. In addition, an intrathecal catheter constructed from PE-10
polyethylene tubing was inserted through an incision in the cisterna magna and the tip
positioned near the lumbar enlargement. The drugs were dissolved in physiological saline
and filtered through a 0.2-μm filter immediately before injection. All drugs were injected in
a volume of 30 μl using an electronic syringe pump at a rate of 30 μl/min. Carbachol (125
nmol in a volume of 0.05μl) was microinjected into the PH and tail and foot withdrawal
response latencies determined at 1, 5, and 10 min post injection. One of the following drugs
was then injected intrathecally: The α2-adrenoceptor antagonist yohimbine, the α1adrenoceptor antagonist WB4101 (97 nmol each, Sigma Chemical Co., or normal saline for
control. Tail and foot withdrawal response latencies were measured at 1 min post injection
and then every five minutes for 45 minutes. Additional groups of rats received intrathecal
injections of one of the antagonists, as described, but without prior PH stimulation.
Experiment 3: Carbachol microinjection in the PH followed by microinjection
of cobalt chloride or normal saline in the A7 area—In the third experiment, rats
were prepared for PH cannulation as previously described. In addition, a second guide
cannula was lowered into the A7 area at the following coordinates: AP +0.6 mm from the
interaural line, lateral 2.1 mm, vertical +2.2 mm, incisor bar set at −2.5 mm. After a baseline
response latency, carbachol (125 nmol) was microinjected into the PH in a volume of 0.5 μl
and response latencies were measured at 1, 5, 10, and 15 minutes. Twenty min after
carbachol injection, cobalt chloride (100 mM/0.5 μl) or saline was microinjected in the A7
area using an electronic syringe pump in the manner described above and response latencies
measured at 1 min, and then every 5 min for 45 min. Additional controls were done in which
saline or cobalt chloride, at doses described previously, was injected near the A7 area in the
absence of PH stimulation.
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Histology—Following testing, animals were overdosed with sodium pentobarbital and
decapitated. The brains were taken and drop fixed in a solution of 10% neutral-buffered
formalin. To determine the position of the microinjection sites relative to the PH and the A7
area, 40- m transverse brain sections were cut from blocks of tissue that contained the
visible injection cannula tract using a cryostat microtome. The sections were rinsed in cold
phosphate-buffered saline PBS, (10 mM), mounted on gel-coated slides, stained with 0.05%
neutral red, dehydrated through a series of alcohols and xylenes, and cover slipped. The
placement of the microinjection cannula was determined by locating the most ventral
position of the cannula tip in serial sections by brightfield microscopy. Tracings of the
appropriate sections were then made using the Neurolucida imaging system
(Microbrightfield, Colchester, VT). The tracings were compared with drawings from the
atlas of Paxinos and Watson to verify that the cannula was within the PH or the A7 cell
group (Paxinos, Watson, 2009).
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Statistical analysis—Treatment groups consisted of between 6 and 13 rats. Tail and foot
withdrawal response latencies are presented as the mean ± S.E.M. Statistical comparisons
among treatment groups across multiple time points were made using two-way repeated
measures ANOVA, and comparisons among means at specific time points were made using
the Holm-Sidak test for multiple post-hoc comparisons. Student’s t-test was used to compare
withdrawal latencies for left and right paws. Foot withdrawal latencies were not significantly
different between left and right paws for any experiment, so response latencies were
averaged for clarity.

3. Results
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Portions of data collected for these experiments were done in laboratories at the University
of Illinois at Chicago (UIC) and at the University of Michigan (UM). To determine whether
there were significant effects of location or time, we compared tail and foot withdrawal
latencies from rats done at UIC with those done at UM. Of the groups done in Experiments
1 and 2, only two differences were found. In Experiment 1, there was a statistically
significant difference between UIC and UM rats for carbachol injection in the PH for tail
flick latency only (4.23 ± 0.16 vs 5.06 ± 0.24 sec; p = 0.005; Student’s T-test). There was no
significant difference for foot withdrawal latencies. In Experiment 2, only rats receiving IT
yohimbine showed differences. For the tail flick latency, UIC rats had an average latency of
2.99 sec vs 3.40 sec for UM rats (Mann-Whitney Rank Sum test, p = 0.002). For the foot
withdrawal test, UIC rats averaged 2.30 ± 0.09 sec vs. 3.13 ± 0.09 sec (p < 0.001; Student’s
T-test). There were no significant differences found for the other Experiment 2 groups. All
of Experiment 3 was done at UM. We determined that discarding data from rats done at UIC
based on clinically insignificant differences comprising fractions of a second would go
contrary to principles of ethical animal usage, so data collected from both laboratories were
included in the analysis.
Effect of carbachol microinjection in the PH on nociception
Microinjection of carbachol in the PH at sites shown in Fig. 1 produced antinociception on
the tail flick test compared to baseline response latencies. Comparisons among the groups
showed a significant effect of carbachol compared to normal saline (two way repeated
measures ANOVA, F = 6.65(2, 153); p = 0.007) that was dependent on time, as evidenced by
a significant interaction effect (p = 0.001). Post hoc comparisons showed significant
differences between the two groups from 1 min through 25 min post carbachol injection
(4.51 ± 0.25 vs. 3.23 ± 0.25 min; carbachol vs saline). Pretreatment of the PH with atropine
significantly reduced the effect of carbachol microinjection at 1, 15, 20, and 25 min after
injection (3.80 ± 0.22; atropine; Fig 2A).
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For the foot withdrawal test, similar results were found. Microinjection of carbachol
produced a significant increase in withdrawal latencies (F =98.41 (2,152); p < 0.001) that was
dependent on time (interaction effect, p < 0.001). Post hoc tests showed a significant
antinociceptive effect following carbachol microinjection compared to control rats (4.73 ±
0.22 vs. 2.31 ± 0.22; carbachol vs. saline, resp.) across all time points, but the results of the
45 min time point must be interpreted with caution, due to the higher baseline of the
carbachol group (Fig. 2B). Atropine pretreatment blocked the antinociceptive effect of
carbachol across the testing period (2.83 ± 0.19; p < 0.05).
Carbachol-induced antinociception: Effect of IT injections of α-adrenoceptor antagonists
Following microinjection of carbachol in the PH at sites similar to those in Fig. 1, IT
injection of α-adrenoceptor antagonists significantly altered tail response latencies (two way
RM ANOVA, F = 7.54(2,207); p = 0.003). As can be seen in Fig. 3A, IT injection of the α2-
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adrenoceptor antagonist yohimbine blocked carbachol-induced antinociception (3.35 ± 0.36
vs 4.43 ± 0.38 sec normal saline; p < 0.05). Conversely, IT injection of the α1-adrenoceptor
antagonist WB4101 increased withdrawal latencies, or facilitated antinociception (5.32 ±
0.36, p < 0.05; Fig. 3A). Intrathecal injection of normal saline had no effect on carbacholinduced antinociception. There was a significant interaction effect (p = 0.035),
demonstrating that the effect of the antagonists was based on time.
As with tail response latencies, IT injection of α-antagonists significantly altered foot
withdrawal latencies following carbachol microinjection in the PH (two way RM ANOVA,
F = 20.21(2,207); p < 0.001). Injection of yohimbine blocked carbachol-induced
antinociception, and injection of WB4101 increased response latencies (2.78 ± 0.22 vs. 4.76
± 0.22 vs. 3.69 ± 0.23 sec, yohimbine, WB4101 and saline resp. p < 0.05; Fig. 3B), which
were dependent on time (interaction effect (p < 0.001). The greatest effect of yohimbine was
seen at 5, 10, and 15 min post antagonist injection, and the strongest effect of WB4101 was
seen at 5 and 10 min after antagonist administration.
Intrathecal α-adrenoceptor antagonists given in the absence of carbachol microinjection in
the PH produced tail and foot withdrawal response latencies that were not significantly
different from normal saline for control (not shown; p > 0.05). This finding indicates that the
connection from the PH to the dorsal horn was not tonically active.
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Effect of cobalt chloride in the A7 area on carbachol-induced PH antinociception
The third experiment tested whether blockade of synaptic activity in the A7 area would also
block carbachol-induced antinociception. Figure 4 shows the approximate locations of
carbachol microinjections made in the PH, and of cobalt chloride or normal saline in the A7
area.
PH-induced antinociception was blocked by microinjection of cobalt chloride into the A7
area as compared to saline controls for tail response latencies (two way RM ANOVA, F =
18.38(1,171), p < 0.001; Fig. 5A). Cobalt chloride blocked the effect of carbachol in the PH
immediately compared to control (3.45 ± 0.37 vs. 5.73 ± 3.7 sec. resp.) and the effect was
not based on time (interaction effect = NS). Interestingly, the baselines of both groups were
somewhat higher than for previous experiments, but microinjection of cobalt chloride
reduced latencies well below baseline levels (Fig. 5A).
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Similar results were seen for the foot withdrawal response latencies. Microinjection of
cobalt chloride into the A7 area significantly reduced PH-induced antinociception (Two way
repeated measures ANOVA, F = 30.88 (1,171), p < 0.001; Fig. 5B), within 10 min after
cobalt chloride injection. The mean withdrawal latencies of rats receiving cobalt chloride
were significantly shorter than rats receiving normal saline in the A7 area (3.04 ± 0.13 vs.
4.08 ± 0.14 sec, resp.), and were not dependent on time (interaction effect, p > 0.05).
Microinjection of either cobalt chloride or normal saline into the A7 cell group in the
absence of PH stimulation resulted in tail and foot withdrawal response latencies that did not
differ significantly from control rats (not shown; p > 0.05).

4. Discussion
Recent studies implicate the PH in nociceptive modulation, but have not examined the
mechanisms through which the PH produces this modulation. Our previous report
demonstrated that PH-induced antinociception in a model of neuropathic pain is mediated in
part by orexins receptors in the spinal cord dorsal horn (Jeong and Holden, 2009). The
present study is the first to examine the PH and its recruitment of spinally-projecting A7
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cells in a nociceptive model of pain. The actions of PH stimulation on spinally projecting
noradrenergic A7 neurons were examined through the use of relatively selective α1- and α2adrenoceptor antagonists in doses and injection volumes shown to block the effects of
activating spinally projecting noradrenergic neurons (Holden et al., 1999; Nuseir and
Proudfit, 2000; Wen et al., 2010). One of the major findings of the current experiments was
that microinjection of 125 nmol carbachol, a dose shown to produce antinociception (Holden
and Naleway, 2001; Holden et al., 2002; Holden et al., 2005; Holden et al., 2009; Jeong and
Holden, 2009), produced antinociception partially blocked by IT administration of the α2adrenoceptor antagonist yohimbine, but facilitated by the IT administration of the α1adrenoceptor antagonist WB4101.
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Several lines of evidence support the conclusion that carbachol stimulation of the PH
produces α-adrenoceptor mediated modulation of nociception in the spinal cord dorsal horn
via connections with the A7 area. First, in Sprague-Dawley rats derived from Sasco, as used
in the present study, A7 noradrenergic neurons project to the spinal cord in a relatively
dense innervation of the dorsal horn (Clark and Proudfit, 1991; West et al., 1993). Second,
while the PH contains a direct projection to the spinal cord, it contains very few tyrosinehydroxylase-immunoreactive neurons, and none of these have been shown to project to the
spinal cord (Abrahamson and Moore, 2001). However, evidence exists that the PH does
innervate the pontine parabrachial area, which contains the A7 cell group (Veazey et al.,
1982; Vertes and Crane, 1996). Third, antinociception from stimulating the PH with
carbachol was reduced or blocked by pretreatment of the PH with the cholinergic antagonist
atropine sulfate, suggesting that carbachol-induced antinociception is mediated by
cholinergic receptors in the PH. These results support and extend the findings of others that
cholinergic receptors play a role in PH mechanisms. For example, injection of muscarinic
and nicotinic antagonists into the PH affect hippocampal theta wave activity (Bocian and
Konopacki, 2004), and choline-induced activation of the α7 nicotinic receptor in
histaminergic tuberomammillary neurons of the PH affect cognition, alertness and sleepwakefulness cycles (Uteshev and Knot, 2005; Gusev and Uteshev, 2010). Fourth, PHinduced antinociception was blocked by application of IT yohimbine, and facilitated by IT
application of WB4101, suggesting that α2-adrenoceptors promote antinociception and α1adrenoceptors promote nociceptive responses. This α-adrenergic opposing response has
been observed following application of morphine (Holden, 1999) or bicuculline (Nuseir and
Proudfit, 2000) directly to the A7 area, and from stimulation of the lateral hypothalamus, an
area that recruits A7 cells as part of the descending nociceptive modulatory system (Holden
and Naleway, 2001; Holden et al., 2002). Furthermore, in the present study, PH-induced
antinociception was blocked following microinjection of cobalt chloride into the A7 cell
group. Cobalt chloride reversibly blocks all synaptic activity within the area of
microinjection (Kretz, 1984). These lines of evidence provide converging support for our
hypothesis that PH-induced antinociception is mediated in part by innervation of the A7
catecholamine cell group.
Our finding that yohimbine blocks PH-induced antinociception supports and extends the
work of others that shows that α2-adrenoceptor antagonists interfere with antinociception, as
yohimbine blocks electrical (Takeda et al., 2006, Wen et al., 2010) or formalin-induced
diffuse noxious inhibitory controls (DNIC) in rat (Wen et al., 2010), the effect of
gabapentin-mediated antinociception in sciatic nerve ligation (Tanabe et al., 2005), and the
antinociceptive effect of tramadol in rat (Li et al., 2012). Atipamazole blocks nerve-injury
neuropathic pain in rat (Bee et al., 2011). In a model of post-operative pain, idazoxan blocks
the effects of milnacipran, a 5-HT and norepinephrine reuptake inhibitor effective for
mechanical hyperalgesia (Obata et al., 2010), and completely reverses the antihyperalgesic
and antiallodynic effects of clonidine, as well as its suppressive effect on ligated sciatic
nerve NR1 phosphorylation in the spinal cord dorsal horn (Roh et al., 2008). It is wellNeuroscience. Author manuscript; available in PMC 2014 February 22.
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documented that α2- adrenoceptors play an important role in the endogenous descending
nociceptive modulatory system with most α2-adrenoceptors residing on the terminals of
descending fibers, local spinal neurons, or central terminals of primary afferent fibers in the
dorsal horn (Fairbanks et al., 2009). While we did not test for the specific α2 receptor
subtype, evidence is supportive for a strong role for the α2a subtype (Wang et al., 2002;
Fairbanks et al., 2009; Roh et al., 2010), and to a lesser extent, the α2c subtype (Chen et al.,
2008; Roh et al., 2010) in providing antinociceptive effects.
Unlike α2- adrenoceptors, α1-adrenoceptor antagonists do not mediate antinociception in
herpes zoster-like skin lesions (Sasaki et al., 2003; Mantovani et al., 2006) or in noxious
heat stimuli in awake monkeys (Thomas et al., 1993), but do potentiate foot withdrawal
responses from microinjection of morphine in the ventrolateral periaqueductal gray (Fang
and Proudfit, 1998). Recently, Zhang and Tan (2011) showed that pretreating cultured dorsal
root ganglion (DRG) cells with either the α1-adrenocpetor antagonists phentolamine or
prazosin inhibits enhanced firing of these cells induced by norepinephrine. Application of
nerve growth factor to DRG cells induces a two-fold increase in α1b-adrenoceptor
expression, but not α2 expression, augmenting neuronal responsiveness to norepinephrine
acting at α1-adrenoceptors and contributing to the development of pain sensitization. Taken
together, these findings lend support to the idea that α1-adrenoceptors facilitate nociception
in the spinal cord.
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A limitation of the present study is the difficulty in determining the precise microinjection
size. The factors considered with size of microinjection are injection spread and amount of
available solution relative to the injector location. Injection spread is affected by the
molecular weight, concentration (Myers and Hoch, 1978; Nicholson, 1985) and water
solubility of the solution, as well as injector tip size (Sakai et al., 1979) and neuroanatomical
features of the injection site (Nicholson, 1985; Sakai et al., 1979; Lum et al., 1984).
Microinjections of 0.5 μl or less limit the average spread of injection (Myers and Hoch,
1978). While recent findings indicate that a 0.5 μl injection of [3H]muscimol into subcortical
structures produces a labeled area of over 5 mm2 15 minutes after injection (Edeline et al.,
2002), others have reported smaller areas of spread. For example, labeled atropine injected
in the hypothalamus (Grossman and Stumpf, 1969), [14C]dopamine injected into the brain
stem (Myers and Hoch, 1978) and [14C]lidocaine and [3H]muscimol injected intracortically
(1 μl over 4 min; Martin, 1991) produce average injection sites of about 1–1.5 mm within
the first 20 min post injection. Our microinjections of 0.5 μl likely fall within these
parameters.
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The amount of available solution relative to the injection location also should be considered.
For example, the amount of [14C]dopamine recovered 0.5 mm from the injection site is only
25% of the amount injected, increasing to 45% 15 min post injection (Myers and Hoch,
1978). Nor does diffusion of solution necessarily equate with neuronal activation. Grossman
and Stumpf (1969) found that labeled atropine at sites away from the immediate
microinjection location is 2,000–10,000 times lower than that needed to effectively block
carbachol-induced behavior changes. Thus, it cannot be assumed that efficacy of the agonist
is uniform across the injection site and is most likely optimally effective nearest the cannula.
Findings from our previous work support this idea, as microinjection of carbachol into the
ventral thalamus just dorsal to the PH (Jeong and Holden, 2009; Holden and Pizzi, 2009),
the nigrostriatal bundle adjacent to the PH (Holden et al., 2002), and the internal capsule
adjacent to the lateral hypothalamus (Holden, Farah, et al., 2005; Holden et al., 2002)
produced withdrawal latencies similar to baseline measurements. Microinjector placements
within the PH and lateral hypothalamus produced longer withdrawal latencies. Finally, we
showed previously that 62 nmol of carbachol, half of the dose used in the present study,
produced response latencies similar to control rats when microinjected into the PH (Jeong
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and Holden, 2009) or the lateral hypothalamus (Holden and Naleway, 2001). Given our use
of a small microinjector tip, the evidence that neurons closer to the microinjector tip are
more likely to be activated than neurons farther away, and the lack of response from a
smaller dose of carbachol, the probability that our results came from stimulating neurons
outside of the PH is small.
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In the present study, unilateral microinjection of carbachol did not produce significant
differences between left and right foot withdrawal latencies. The PH projection to the
parabrachial area, including the A7 area, is predominantly unilateral, but there is a small
contralateral projection (Vertes and Crane, 1996). Similarly, the A7 cell group sends axons
to both the ipsilateral and contralateral dorsal horn (Clark and Proudfit, 1991). We found
that unilateral microinjection of cobalt chloride in the A7 area completely blocked PHinduced antinociception for both feet. If the contralateral connection between the left PH and
A7 area was significantly involved, such a blockade would not be expected for the right foot
because the contralateral PH projection would activate descending input to the right dorsal
horn. It seems likely that the lack of foot withdrawal differences is due to the bilateral
projection of the A7 cell group to the dorsal horn because blockade of synaptic activity in
the left A7 cell group prevented PH-induced antinociception in both feet. This idea is
supported by the findings that unilateral stimulation of the A7 cell group either electrically
(Yeomans et al., 1992) or chemically (Yeomans and Proudfit, 1992) produces bilateral
effects.
In summary, the results of the present study demonstrated that microinjection of carbachol
in the PH produces antinociception facilitated by α2-adrenoceptors and opposed by α1adrenoceptors in the spinal cord dorsal horn. The converging evidence is suggestive that the
PH makes connections in part with spinally descending noradrenergic neurons in the A7
catecholamine cell group that act at the dorsal horn to exert opposing effects on nociception.
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•

Stimulating the posterior hypothalamus (PH) produces antinociception.

•

Dorsal horn α2-adrenoceptors mediate antinociception.

•

Dorsal horn α1-adrenoceptors mediate an opposing hyperalgesic effect.

•

Blockade of spinally descending noradrenergic A7 cells blocks PH
antinociception.

•

PH-induced antinociception is mediated in part by connections with the A7 cell
group.
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Fig. 1.
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The location of carbachol microinjection sites in the PH for tail response latencies in
Experiment 1. Most of the injection sites were located within the border of the PH between
AP −3.60 and −3.80 mm from bregma. The symbols represent the values of the differences
between baseline tail response latencies and those at 15 min after microinjection of
carbachol (125 nmol) as follows: (△) 2–3.9 sec; (△) 4–5.9 sec; (□) 6–8 sec. Injection sites
located in the lateral hypothalamus (●) and the hippocampus (●) elicited antinociceptive
responses and were excluded from data analysis. AMG, amygdala; ic, internal capsule; LH,
lateral hypothalamus; LV, lateral ventricle; PH, posterior hypothalamus; VM, ventromedial
thalamic nucleus; VPL, ventral posterolateral thalamic nucleus; VPM; ventral posteromedial
thalamic nucleus; ZI, zona incerta.

Neuroscience. Author manuscript; available in PMC 2014 February 22.

Jeong et al.

Page 16

NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript

Fig. 2.

Microinjection of carbachol in the PH produced time-dependent increases in nociceptive tail
response latencies. Following a baseline response latency measurement, normal saline or
carbachol (125 nmol) was microinjected into the PH at time 0. Time-course changes in (A)
tail response latencies or (B) foot withdrawal latencies produced by microinjection of saline
(□; n = 6) or carbachol (○; n = 6). In a separate group of rats (◇; n = 9), pretreatment with
atropine in the PH reduced tail flick latencies and blocked foot withdrawal latencies
following carbachol microinjection. Mean response latencies ± SEM. *p< 0.05, carbachol vs
saline; #p < 0.05, carbachol vs. atropine.
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Fig. 3.

Antinociception from microinjection of carbachol (125 nmol) in the PH was blocked by
intrathecal injection of the α2-adrenoceptor antagonist yohimbine, but facilitated by
injection of the α1-adrenoceptor antagonist WB4101. (A) Carbachol (Carb) was injected at
-17 min and three post drug tail response measurements were made at -15, -10 and -5 min.
Either Yohimbine (YOH, □, n = 10), WB4101, (○, n = 9) or saline (◆, n = 7) was injected
intrathecally at time -1. (B) Time course of the effects of intrathecal injection of either YOH,
WB4101, or saline following carbachol microinjection in the PH on foot withdrawal
response latencies. Mean response latencies ± SEM. * p < 0.05.
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Fig. 4.

The location of microinjection sites in the PH and A7 cell group for tail response latencies in
Experiment 3. Most of the injection sites for carbachol/cobalt chloride (A) and carbachol/
saline (B) were located within the PH between AP −3.60 and −4.16 from bregma at 10 min
post carbachol injection. The symbols represent the values of the differences between
baseline tail response latencies and those at 15 min after microinjection of carbachol (125
nmol) as follows: (△) 2–3.9 sec; (○) 4–5.9 sec; (□) 6–8 sec. Injection sites located in the
cortex, dorsal thalamus, zona incerta (■) and ventral hypothalamus (●) elicited
antinociceptive responses and data were excluded from analysis. Microinjections of cobalt
chloride (C; ○) and saline (D; ●) were located in the A7 area (✶) approximately AP −8.72 –
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10.04 from bregma. A7, A7 catecholamine cell group; Aq, Aqueduct of Sylvius; AMG,
amygdala; Ic, inferior colliculus ic, internal capsule; LH, lateral hypothalamus; LV, lateral
ventricle; MCP, middle cerebellar peduncle; PH, posterior hypothalamus; pyr, pyramids;
SCP, superior cerebellar peduncle;VM, ventromedial thalamic nucleus; VPL, ventral
posterolateral thalamic nucleus; VPM; ventral posteromedial thalamic nucleus; ZI, zona
incerta.
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Fig. 5.

Antinociception produced by microinjection of carbachol in the PH was blocked by
microinjection of cobalt chloride in the A7 area. (A) Following a baseline measurement at
-25 min, carbachol (Carb) was microinjected in the PH and four tail response latencies were
measured. Either cobalt chloride (○; CoCl; n = 11) or saline (●; n = 13) was microinjected
in the A7 area. Cobalt chloride significantly reduced tail flick latencies across all time points
compared to saline controls (p < 0.05). Mean latency values ± SEM are plotted on ordinate
as a function of time (min). (B) Cobalt chloride microinjected in the A7 area also blocked
PH-mediated antinociception on the foot withdrawal test (○; p < 0.05). Normal saline
microinjected near the A7 area (●) did not alter nociceptive responses.
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